Personal Cfo Solutions, LLC Adaptimmune Therapeutics PLC Transaction History

Personal Cfo Solutions, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$1.06 - $2.41 $3,180 - $7,230	-3,000 Reduced 13.4%	19,388 $21,000
Q2 2022 Aug 05, 2022	SELL	$1.33 - $2.28 $5,320 - $9,120	-4,000 Reduced 15.16%	22,388 $38,000
Q4 2021 Feb 11, 2022	SELL	$3.5 - $5.68 $35,000 - $56,800	-10,000 Reduced 27.48%	26,388 $99,000
Q3 2021 Nov 18, 2021	BUY	$3.44 - $6.37 $20,640 - $38,220	6,000 Added 19.74%	36,388 $188,000
Q2 2021 Jul 22, 2021	BUY	$3.86 - $5.78 $63,690 - $95,370	16,500 Added 118.81%	30,388 $129,000
Q1 2021 Apr 21, 2021	BUY	$4.9 - $6.83 $9,800 - $13,660	2,000 Added 16.82%	13,888 $74,000
Q4 2020 Feb 09, 2021	SELL	$4.0 - $9.2 $55,636 - $127,962	-13,909 Reduced 53.92%	11,888 $64,000
Q3 2020 Nov 02, 2020	BUY	$7.66 - $10.78 $197,605 - $278,091	25,797 New	25,797 $0

152M

78.5K

36.5K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $121M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.